Recombinant granulocyte colony-stimulating factor-transferrin fusion protein as an oral myelopoietic agent.
about
Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make BiobettersSoluble prokaryotic overexpression and purification of bioactive human granulocyte colony-stimulating factor by maltose binding protein and protein disulfide isomerase.Accumulation of transferrin in Caco-2 cells: a possible mechanism of intestinal transferrin absorptionHuman growth hormone-transferrin fusion protein for oral delivery in hypophysectomized rats.Expression, purification, and characterization of recombinant human transferrin from rice (Oryza sativa L.).Design and characterization of structured protein linkers with differing flexibilities.Characterization of transferrin receptor-mediated endocytosis and cellular iron delivery of recombinant human serum transferrin from rice (Oryza sativa L.).Transferrin as a model system for method development to study structure, dynamics and interactions of metalloproteins using mass spectrometryEngineering superactive granulocyte macrophage colony-stimulating factor transferrin fusion proteins as orally-delivered candidate agents for treating neurodegenerative disease.Construction of Marker-Free Transgenic Strains of Chlamydomonas reinhardtii Using a Cre/loxP-Mediated Recombinase SystemInvestigating the Selectivity of Metalloenzyme Inhibitors in the Presence of Competing Metalloproteins.Mass spectrometry-guided optimization and characterization of a biologically active transferrin-lysozyme model drug conjugate.Approaches for enhancing oral bioavailability of peptides and proteinsTargeting of the CNS in MPS-IH using a nonviral transferrin-alpha-L-iduronidase fusion gene product.Pharmacokinetics of recombinant bifunctional fusion proteins.Functional antibody CDR3 fusion proteins with enhanced pharmacological properties.Protein engineering for cardiovascular therapeutics: untapped potential for cardiac repair.An antibody with a variable-region coiled-coil "knob" domain.Engineering of therapeutic proteins production in Escherichia coli.Fusion protein linkers: property, design and functionality.Receptor-mediated activation of a proinsulin-transferrin fusion protein in hepatoma cells.Design of an in vivo cleavable disulfide linker in recombinant fusion proteins.Insertion of the designed helical linker led to increased expression of tf-based fusion proteinsEffect of flexible linker length on the activity of fusion protein 4-coumaroyl-CoA ligase::stilbene synthase.SynLinker: an integrated system for designing linkers and synthetic fusion proteins.High-level production of animal-free recombinant transferrin from Saccharomyces cerevisiae.Preparation of monoPEGylated Cyanovirin-N's derivative and its anti-influenza A virus bioactivity in vitro and in vivo.Extending the serum half-life of G-CSF via fusion with the domain III of human serum albumin.Effects of receptor binding on plasma half-life of bifunctional transferrin fusion proteins.In vitro characterization of an acetylcholine receptor-transferrin fusion protein for the treatment of myasthenia gravis.A fusion protein derived from plants holds promising potential as a new oral therapy for type 2 diabetes.Biocompatibility, absorption and safety of protein nanoparticle-based delivery of doxorubicin through oral administration in rats.Novel production method of innovative antiangiogenic and antitumor small peptides in Escherichia coli.Synthesis and Biological Evaluation of a Degradable Trehalose Glycopolymer Prepared by RAFT Polymerization.Studies on lactoferrin nanoparticles of gambogic acid for oral delivery.Characterization and Oral Delivery of Proinsulin-Transferrin Fusion Protein Expressed Using ExpressTec.Construction, Purification, and Characterization of a Homodimeric Granulocyte Colony-Stimulating Factor.A fusion protein consisting of the exopeptidases PepN and PepX-production, characterization, and application.
P2860
Q26801319-20552F3A-86BE-4A36-B916-532258007363Q31152401-FD9F7D58-D396-414C-9864-8C8BC76E8849Q33288541-D929E132-CC64-4B8D-8FDA-30FF8536801CQ33625084-F2521386-C73A-4B71-88F3-ABA97883A3DBQ34079713-65B231AC-B506-4E4C-8C8F-C7995277565DQ34313196-EB0E990F-687C-4224-A926-C33669E5167BQ34495547-AFADFFCE-1711-47E1-82F9-D1FD89790380Q35511065-4D7A21C3-9C8F-4C9D-B2E4-418816796F23Q35571088-116A8273-157A-4F42-A8E3-92AA3CD8CD53Q36114350-D6DC6885-D10A-4FBA-9032-2971CE1A79A7Q36316167-2CA116D1-C1BB-4BC7-90A1-1E865C32F4C8Q36824142-2227C8CC-AFC8-4A30-A849-47F7C26B5581Q36922557-1D7E6657-7C8E-4999-BE13-FA6F31E5C55CQ36953167-806663A7-0607-4B85-A71B-5A41F37539F0Q37033032-4C1619F1-2DA6-4910-A981-43B0FA53475DQ37197904-64A658BA-9E82-4445-8F52-6018831C7DDBQ37405644-C4A21D8A-0EBC-4820-8061-B9254234EAF1Q37588398-FE8C995C-031F-4908-A647-BB40A3FCF37DQ37807056-43F89699-A6FA-43B5-B9A8-AC6D97A23559Q38048516-16558B99-69E2-4BA0-98A6-5B8B9A4FA468Q38746305-45E30403-B114-43B8-B4DF-D39A6101B422Q39682781-53A50508-C46E-422D-BD46-9F4C8BE1562AQ39918619-F55D904F-5286-4CB5-A48B-7080643B199BQ40442426-37ED6312-3845-459A-8448-8C4CDB711F87Q40677020-A664AD61-5DFC-4E8D-B062-4E8289109428Q41127405-EB95BBC6-9D57-4A64-A3D1-0BE03F5BA2B8Q41465210-707F2822-993C-47F9-9E38-24A43482A3A3Q42109024-8DC4E956-6E45-43BD-B0D9-82BBEE11F82FQ42572918-988881AE-453D-4851-AFA9-49CA916909CFQ43093968-BA7B0E41-E1D0-4257-A41E-46CA620A9A25Q43499161-22A46666-4F03-4172-AE01-9BA4A10BC5D9Q44636337-BDA5C51C-2D0E-4780-8A97-DDC25FF12A0CQ45330895-08099634-1BB3-4AE6-B9CB-08E54E726401Q47282212-14D1A0C0-9C14-4E7A-982A-007E91E5862CQ47776048-3F9596DF-3919-4C12-B992-0B01B463B32DQ48159203-2D03F3BC-297E-4D19-B73C-3B0C76608C4DQ50882900-C95AF51A-32B9-4DEB-8EFF-E4C7AAAB5340Q54248045-35846F95-0B81-46C3-8E50-A6CF85275AC9
P2860
Recombinant granulocyte colony-stimulating factor-transferrin fusion protein as an oral myelopoietic agent.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Recombinant granulocyte colony ...... as an oral myelopoietic agent.
@ast
Recombinant granulocyte colony ...... as an oral myelopoietic agent.
@en
type
label
Recombinant granulocyte colony ...... as an oral myelopoietic agent.
@ast
Recombinant granulocyte colony ...... as an oral myelopoietic agent.
@en
prefLabel
Recombinant granulocyte colony ...... as an oral myelopoietic agent.
@ast
Recombinant granulocyte colony ...... as an oral myelopoietic agent.
@en
P2093
P2860
P356
P1476
Recombinant granulocyte colony ...... as an oral myelopoietic agent.
@en
P2093
David K Ann
Wei-Chiang Shen
P2860
P304
P356
10.1073/PNAS.0500062102
P407
P577
2005-05-03T00:00:00Z